Patricia S. Andrews, MD

Dr. Andrews joined the Vanderbilt faculty in 2019 after completing her Geriatric Psychiatry Fellowship at the Indiana University School of Medicine. She is also a former Honors Scholar of the Geriatric Mental Health Foundation and board-certified psychiatrist from Einstein Medical Center, Philadelphia.

Dr. Andrews is a 2023 Scholar, which is a grant awarded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to study how prior COVID-19 infection may accelerate cognitive decline in the ADNI cohort. She is Site Co-Principal Investigator for the Alzheimer’s Clinical Trials Consortium (ACTC) since Vanderbilt became an ACTC site in 2023. Dr. Andrews is the Site-Principal Investigator of the AHEAD Study, an NIA funded study of Lecanemab, a recently approved FDA treatment for Alzheimer’s Disease. Additionally, she is co-investigator in multiple NIH funded projects on cognitive impairment, geriatric depression, and dementia.